PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
This week's stories show how fast attackers change their tricks, how small mistakes turn into big risks, and how the same old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback